NYSE:DOCS 6 December 2025 - 8 August 2026

Doximity ended one of its strongest trading weeks in years after investors embraced its clinical AI strategy, even as management acknowledged that the new products have yet to contribute meaningful reported revenue. The shares closed at $27.40 on Friday, up 32.6% for the day and about 31% for the week.

Doximity stock jumped 69.9% in premarket trading on Friday, pointing to an increase of roughly $2.6 billion in equity value. The surge came after the company raised its annual revenue outlook by $6 million, though the midpoint for annual EBITDA was lowered by $10 million.